![James M. Norman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James M. Norman
Vertrieb & Marketing bei Molecular Imaging, Inc.
Profil
James M.
Norman is currently the Vice President-Sales at Molecular Imaging, Inc. Prior to this, he worked as the Head-Commercial Development at Maccine Pte Ltd.
and as the Manager-International Affairs Group at SNBL Clinical Pharmacology Center, Inc. He also worked as a Principal at SNBL USA Ltd.
Mr. Norman completed his undergraduate degree at Southern Cross University.
Aktive Positionen von James M. Norman
Unternehmen | Position | Beginn |
---|---|---|
Molecular Imaging, Inc.
![]() Molecular Imaging, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Imaging, Inc. provides research services supported by extensive in vivo imaging capabilities. Its services include oncology pharmacology, immuno-oncology, imaging, radiation, and in vivo biodistribution. The company was founded by Wilbur R. Leopold, John Fleming, and Patrick McConville in 2003 and is headquartered in Ann Arbor, MI. | Vertrieb & Marketing | - |
Ehemalige bekannte Positionen von James M. Norman
Unternehmen | Position | Ende |
---|---|---|
SNBL USA Ltd.
![]() SNBL USA Ltd. Medical/Nursing ServicesHealth Services SNBL USA Ltd. provides general toxicology, acute radiation syndrome, apheresis, CNS drug delivery, immunohistochemistry, tissue cross reactivity and biological services. The company is headquartered in Everrett, WA. | Corporate Officer/Principal | - |
Maccine Pte Ltd.
![]() Maccine Pte Ltd. Pharmaceuticals: MajorHealth Technology Maccine is a Singapore-based preclinical contract research organization providing innovative discovery research and quality safety-assessment services to the global biotechnology and pharmaceutical industry. It offers creating translational value in the preclinical research space and significant investment in technology, people and science has ensured Maccine's position at the forefront of global preclinical research. Maccine is an established preclinical contract research organization providing innovative discovery support and regulatory safety assessment services. Operating on a collaborative partnering model, Maccine has developed a portfolio of in vivo assays in key therapeutic areas including Neurology, Psychiatry, Metabolic Disorders, Pain & Inflammation, Oncology, Musculoskeletal Disorders and Women's Health. Naturalistic models, clinical biomarkers and clinical technology platforms are employed to better represent the clinical disease state. The team is supported by significant investment in high-end technology and access to a world class scientific community. | Corporate Officer/Principal | - |
SNBL Clinical Pharmacology Center, Inc. | Corporate Officer/Principal | - |
Ausbildung von James M. Norman
Southern Cross University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Molecular Imaging, Inc.
![]() Molecular Imaging, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Imaging, Inc. provides research services supported by extensive in vivo imaging capabilities. Its services include oncology pharmacology, immuno-oncology, imaging, radiation, and in vivo biodistribution. The company was founded by Wilbur R. Leopold, John Fleming, and Patrick McConville in 2003 and is headquartered in Ann Arbor, MI. | Commercial Services |
SNBL Clinical Pharmacology Center, Inc. | |
SNBL USA Ltd.
![]() SNBL USA Ltd. Medical/Nursing ServicesHealth Services SNBL USA Ltd. provides general toxicology, acute radiation syndrome, apheresis, CNS drug delivery, immunohistochemistry, tissue cross reactivity and biological services. The company is headquartered in Everrett, WA. | Health Services |
Maccine Pte Ltd.
![]() Maccine Pte Ltd. Pharmaceuticals: MajorHealth Technology Maccine is a Singapore-based preclinical contract research organization providing innovative discovery research and quality safety-assessment services to the global biotechnology and pharmaceutical industry. It offers creating translational value in the preclinical research space and significant investment in technology, people and science has ensured Maccine's position at the forefront of global preclinical research. Maccine is an established preclinical contract research organization providing innovative discovery support and regulatory safety assessment services. Operating on a collaborative partnering model, Maccine has developed a portfolio of in vivo assays in key therapeutic areas including Neurology, Psychiatry, Metabolic Disorders, Pain & Inflammation, Oncology, Musculoskeletal Disorders and Women's Health. Naturalistic models, clinical biomarkers and clinical technology platforms are employed to better represent the clinical disease state. The team is supported by significant investment in high-end technology and access to a world class scientific community. | Health Technology |